Jennifer McMahon is a Partner at Seroba, having joined the firm's investment team as an Investment Analyst and progressed to Partner in 2022. She has a background in pharmacology and invests across medical devices and therapeutics. She sits on the boards of Palliare and Deciphex and holds observer roles at Shorla Pharma and ShiraTronics; her prior boards include Biosensia and Endotronix, acquired by Edwards Lifesciences. She was a founding member of the Irish chapter of Level20 in 2019 and became International Chair of its European chapters in 2021. She guest lectures on venture capital at University College Dublin, Trinity College Dublin and the Royal College of Surgeons in Ireland.
Education
Honours degree in Pharmacology, University College Dublin
Master's degree in Biotechnology and Business
Diploma in Company Direction, Institute of Directors (UK)